New Drug Extends Life for Hard-to-Treat Breast Cancer

Women with triple negative breast cancer now have a powerful new treatment option that nearly doubles the time before their disease progresses.

The FDA just approved Datroway, giving hope to patients who previously had limited choices beyond traditional chemotherapy.